Phase I trials are the first stage of clinical testing in humans, primarily focused on assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. They typically involve a small number of healthy volunteers or patients and aim to determine the appropriate dosage range and identify side effects.

Phase I Trials

Clinical testing

Safety assessment is a systematic process used to identify potential hazards and evaluate risks associated with a product, process, or system to ensure it meets safety standards and regulations. It involves qualitative and quantitative analyses to mitigate risks and protect people, property, and the environment.

Safety Assessment

Tolerability assessment

Pharmacokinetics is the study of how drugs move through the body, encompassing absorption, distribution, metabolism, and excretion processes. It is crucial for understanding drug action, optimizing dosing regimens, and ensuring therapeutic efficacy while minimizing toxicity.

Pharmacokinetics

Pharmacodynamics is the study of how drugs affect the body, focusing on the mechanisms of action, the relationship between drug concentration and effect, and the therapeutic and toxic effects. It helps in understanding the drug's efficacy, potency, and safety profile, which are crucial for optimizing therapeutic regimens.

Pharmacodynamics

Healthy Volunteers

Patients are people who go to the doctor when they feel sick or need a check-up to stay healthy. Doctors and nurses help patients by giving them medicine and advice to feel better and stay strong.

Patients

Appropriate dosage range

Side effects refer to unintended consequences of an action, often seen in pharmaceuticals where they are secondary effects of a drug apart from its intended therapeutic outcomes. Understanding side effects is crucial for evaluating the risk-benefit profile of interventions and ensuring patient safety in medical treatments.

Concepts

Relevant Degrees

Your Lessons